SCHEMBL29164752

SCHEMBL29164752

Cc1cc(NC(=O)c2cc(Cl)ccc2C)n[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.64
RAB9A P51151 10/20 0.64
CCNA2 P20248 3/20 0.56
CDK2 P24941 3/20 0.56
CCNA1 P78396 3/20 0.56
ATM Q13315 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 1/20 0.49
SORT1 Q99523 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
NR1I2 O75469 1/20 0.47
AHR P35869 1/20 0.47
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30822684 1.00 NPC1 (0.64) NPC1RAB9ACCNA2CDK2CCNA1
SCHEMBL29165008 0.81 HDAC1 (0.48) NPC1RAB9AALDH1A1SORT1HDAC1
SCHEMBL30822692 0.81 HDAC1 (0.48) NPC1RAB9AALDH1A1SORT1HDAC1
SCHEMBL6341557 0.76 CCNA2 (0.85) NPC1RAB9ACCNA2CDK2CCNA1
SCHEMBL17538513 0.74 CCNA2 (0.71) NPC1RAB9ACCNA2CDK2CCNA1
SCHEMBL29164652 0.74 RAB9A (0.62) NPC1RAB9ACCNA2CDK2CCNA1
SCHEMBL6339310 0.74 NPC1 (0.66) NPC1RAB9ACCNA2CDK2CCNA1
SCHEMBL9132190 0.74 CCNA2 (0.66) NPC1RAB9ACCNA2CDK2CCNA1
SCHEMBL15613375 0.73 NPC1 (0.67) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL25143450 0.72 CCNA2 (0.63) NPC1RAB9ACCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117659001-A Aminopyrimidine derivatives and their use in medicine 广东东阳光药业股份有限公司 2024-03-08 CN disclosed